Red Light Therapy for Horses: What the Research Actually Shows — Strong Mechanism, Thin Clinical Proof, and an Honest Look at the Evidence
Share
Search "red light therapy horse research" and you will find two extremes: marketing pages presenting the therapy as a proven miracle, and sceptics dismissing it as pseudoscience. The honest picture sits between them, and it is more interesting than either. The cellular mechanism of red light therapy (photobiomodulation, or PBM) is genuinely well established — photons at red and near-infrared wavelengths are absorbed by cytochrome c oxidase in the mitochondria, a pathway mapped across mammals in a very large body of work. Laboratory studies on equine cells are promising. But the layer that would actually prove clinical benefit in living horses — controlled clinical trials — is thin, and the results that do exist are mixed, including at least one well-designed randomised study that found no benefit at all. This article maps what the research actually shows, layer by layer, and cites the real studies so you can check them yourself. Our guide to how PBM works covers the mechanism in depth.
Two things separate an honest reading of this research from a misleading one. The first is understanding evidence tiers: a study showing that cells in a dish respond to light does not prove that a horse's tendon heals faster, and a case series with no control group cannot prove that the light — rather than rest, time, or other care — caused an improvement. The second is a genuinely important equine-specific wrinkle that most sources ignore: how much light actually reaches the target tissue depends heavily on coat colour, skin thickness, and dose. Real equine penetration studies show that dark hair transmits far less light than light hair, which means a device applied over a dark coat may deliver only a fraction of the intended energy to the tissue underneath. Our guide to wavelength and penetration depth covers this in practical terms.
Why does this honesty matter, on a site that sells the devices? Because a therapy with a strong mechanism, promising laboratory support, and a developing — if still limited — clinical base is worth using as a supportive, complementary measure with realistic expectations. It is not worth overselling as settled science, because that sets owners up for disappointment and erodes trust. The research supports using red light therapy thoughtfully, alongside good management and veterinary care, and staying sceptical of anyone who tells you the science is finished. For how to put a realistic routine together, our guide to building a routine is the practical companion to this evidence review.
The Short Answer
The mechanism is well established and equine cells respond to light in the lab — but equine clinical trials are limited and mixed, including a randomised study that found no benefit for wound healing. The research supports cautious, supportive use, not confident claims of proven healing.
Strong evidence: the cellular mechanism (cytochrome c oxidase as the chromophore), characterised across mammals over decades.
Promising evidence: in vitro equine studies (mesenchymal stem cells, tendon cells) showing dose-dependent cellular responses.
Limited and mixed evidence: equine clinical trials. Some case series report benefit; a well-designed randomised controlled wound study found none, and reviews call animal results inconsistent and treatment parameters unstandardised.
The under-discussed caveat: penetration studies show coat colour, skin, and dose strongly affect how much light reaches the tissue — so delivered dose, not applied dose, is what matters.
How to Read the Evidence: The Tiers That Matter
Almost every argument about whether red light therapy "works" for horses comes down to which tier of evidence someone is citing — and whether they are honest about its limits. Before looking at specific studies, it helps to understand what each tier can and cannot tell you.
| Evidence tier | What it can tell you | What it cannot tell you |
|---|---|---|
| Mechanistic / cellular | How the therapy works biologically — the chromophore, the pathways, the dose-response. This is well established for PBM | Whether it produces a meaningful clinical result in a living horse. Plausibility is not proof |
| In vitro (cells in a dish) | That equine cells respond to light — proliferation, collagen, cytokine changes, in controlled conditions | Whether the same happens inside a horse, where light must penetrate skin and coat to reach the cells |
| In vivo animal models | Effects in living tissue, often in rodents — closer to reality, useful for direction | Whether results transfer to horses, which differ greatly in size, tissue depth, and coat |
| Case series (no control group) | What happened to a group of treated horses — useful for generating hypotheses | Whether the light caused the outcome, because there is no untreated comparison. Rest and time also heal |
| Randomised controlled trial (RCT) | The strongest test — treated vs control, randomised and ideally blinded. This is where clinical proof lives | Little, when done well — but equine RCTs are few, often small, and results vary |
| Systematic review | A synthesis of all the above, weighing quality — the best summary of the overall state of evidence | More than the underlying studies contain. A review of weak studies is still a review of weak studies |
The single most common error in red light marketing
The error is citing a lower tier as if it were a higher one — presenting a cell-culture study, a rodent experiment, or a human trial as though it proves clinical benefit in horses. You will see this constantly: "studies show red light accelerates healing," followed by references that are in vitro, in rodents, or in people, none of which establish that the therapy heals a living horse.
This does not mean the lower tiers are worthless — mechanism and in vitro work are how good therapies are discovered, and PBM has genuinely strong evidence at those tiers. It means you should ask, every time you see a claim: what tier is this evidence, and is it being represented honestly? The gap between "equine cells respond to light in a dish" and "your horse's tendon will heal faster" is exactly the gap the equine clinical research has not yet closed.
The Strong End: Mechanistic and In Vitro Research
This is where the evidence for PBM is genuinely robust, and it is the reason the therapy is biologically plausible rather than fringe.
The mechanism is well characterised
Decades of photobiomodulation research have identified cytochrome c oxidase — an enzyme in the mitochondrial electron transport chain — as the primary photoacceptor for red and near-infrared light, with downstream effects on ATP production, nitric oxide release, and reactive oxygen species signalling (Passarella and Karu, 2014; Hamblin and colleagues). This mechanism is not specific to any one species; the same mitochondrial chromophore is present across mammals, which is why findings in one species are considered mechanistically relevant to others. At the level of "how could this possibly work," the answer is well established.
Equine cells respond to light in the laboratory
Several studies have tested light directly on equine cells. Work on equine bone-marrow-derived mesenchymal stem cells has examined how laser irradiation affects cell viability, proliferation, and cytokine expression (Peat et al., 2018), and further studies have investigated photobiomodulation effects on equine mesenchymal stem cells (Zielinska et al., 2020). Broader tendon-cell research across species has reported light-stimulated collagen synthesis and matrix metalloproteinase activity relevant to tendon repair. The consistent theme is that equine and mammalian cells do respond to appropriate doses of light in controlled conditions, in a dose-dependent way.
What this tier genuinely establishes — and what it does not
Together, the mechanistic and in vitro research establishes something real and important: red light therapy is biologically plausible, it acts through a well-defined cellular pathway, and equine cells are responsive to it. That is a stronger foundation than many complementary therapies can claim. What it does not establish is clinical benefit in a living horse — because in a dish, the light reaches the cells directly, with no skin, coat, or tissue depth in the way, and at a precisely controlled dose. Inside a horse, both of those conditions change, which is exactly why the next two sections matter so much.
The Equine Penetration Problem: Does the Light Even Reach the Target?
This is the most under-discussed area of equine PBM research, and arguably the most practically important — because it sits between the promising laboratory results and the disappointing clinical ones, and helps explain the gap.
Equine-specific penetration studies have measured how much light actually passes through horse skin and tendon. An investigation into penetration through the equine tendon in living horses was published as early as 2007 (Ryan and Smith, 2007), and a detailed ex vivo study measured how efficiently laser light passes through equine skin and the superficial and deep digital flexor tendons (Duesterdieck-Zellmer and colleagues, 2016). The findings are striking and consistent: penetration depends heavily on coat colour, with light-coloured hair transmitting far more light than dark hair, and it is also strongly affected by skin preparation, skin colour, skin thickness, and wavelength. Clipping and shaving hair substantially increased the energy that reached the tissue.
Why this changes how you read every other study
Here is the implication that ties the whole evidence picture together: the dose applied at the skin surface is not the dose the tissue receives. If a device delivers a given amount of energy at the surface, only a fraction of it may reach a deep tendon — and over a dark coat, that fraction can be small. The 2016 penetration study concluded plainly that to deliver, to an equine tendon, the energy doses known to affect cells in the laboratory, you have to account for skin preparation, colour, thickness, and wavelength. The same study noted that the clinical effectiveness of low-level laser therapy for musculoskeletal conditions such as tendon injuries and osteoarthritis is not universally accepted, because studies have not unequivocally shown clinical benefit.
This is the missing link. Laboratory cells respond to light at a known dose. But if a clinical study cannot get that dose to the tissue — because of coat, skin, and depth — then a null result may reflect underdosing rather than a therapy that does not work. Delivered dose, not applied dose, is what determines whether the biology has a chance to happen.
The Honest Middle: What the Equine Clinical Trials Found
This is the tier that would actually prove clinical benefit — controlled studies in living horses — and it is where the evidence is thinnest and least flattering. Here are the real equine studies, represented accurately, including the ones that did not find what device marketing would prefer.
| Study | What it tested and found | Evidence tier |
|---|---|---|
| Michanek et al., 2021 (Equine Veterinary Journal) — wound healing | Randomised, blinded, controlled study in 8 horses, using each horse as its own control. LED red (~637 nm) and near-infrared (~956 nm) light on experimental neck wounds. Found no clinically relevant benefit versus untreated wounds — and treated wounds took longer to heal completely | RCT (strongest) — a null result |
| Pluim et al., 2018 (Research in Veterinary Science) — tendon/ligament | Follow-up of 150 sport horses with tendinopathy or desmopathy treated with high-power laser therapy, reporting favourable clinical and ultrasonographic outcomes | Case series (no control group) — suggestive, not proof |
| Haussler et al., 2020 (Journal of Equine Veterinary Science) — back pain | Examined the effects of low-level laser therapy and chiropractic care on back pain in Quarter horses | Controlled equine study — one of few in this area |
| Peat et al., 2018 / Zielinska et al., 2020 — equine cells | In vitro effects of laser and photobiomodulation on equine mesenchymal stem cells (viability, proliferation, cytokines) | In vitro — mechanism support, not clinical proof |
The wound study deserves attention
The Michanek 2021 study is worth understanding in detail, because it is exactly the kind of high-quality evidence the field needs more of — and it is a null result. It was randomised and blinded, and it used an elegant design in which each horse received a treated wound and an untreated control wound, removing between-horse variation. After daily light treatment, there were no significant differences in swelling or wound area between treated and control wounds, and the treated wounds actually took longer to close completely. The authors concluded that the results did not indicate any clinically relevant positive effect of the light on wound healing in horses.
An honest site does not hide this study — it engages with it. Two things are worth noting. First, the applied doses were relatively low (in the low single-digit milliwatts per square centimetre), which, combined with the penetration findings above, raises the real possibility of underdosing. Second, one well-designed null study does not prove a therapy never works — but it absolutely disproves the claim that the benefit is established and reliable. Anyone citing "research" to sell you guaranteed wound healing is ignoring the best-designed equine wound study on the books.
What the Reviews Conclude
Systematic reviews sit at the top of the evidence pyramid because they synthesise everything below them. Two are directly relevant.
- A systematic literature review of laser therapy in veterinary medicine (Millis and Bergh, 2023, in Animals) examined the evidence for laser therapy as a complementary and alternative veterinary modality across species — the kind of broad, quality-weighted synthesis the field needs.
- A review of wound photobiomodulation outcomes in animal models (Lopez and Brundage, 2019) found that rodent studies were generally beneficial at red and near-infrared wavelengths, but concluded that results across rabbit, canine, and equine models remain inconsistent, and that more studies are needed to explain those inconsistencies and to establish correct treatment parameters for each species.
The synthesis in one honest sentence
Across the mechanistic strength, the promising in vitro equine data, the real penetration constraints, the limited and mixed clinical trials, and the review-level conclusions, the fair summary is this: photobiomodulation has a strong mechanistic and laboratory foundation, but equine clinical results are inconsistent, treatment parameters are not standardised, and high-quality equine trials are too few to consider clinical benefit proven for most specific conditions. That is neither an endorsement of hype nor a dismissal — it is where the science actually stands.
Laser vs LED: A Research Distinction That Matters for Buyers
There is a detail in the research that consumer marketing rarely mentions: much of the equine clinical literature uses lasers, while most consumer red light devices use LEDs — and the distinction affects how directly the research applies to a home device.
| Laser (LLLT / high-power laser) | LED (most consumer devices) | |
|---|---|---|
| Light property | Coherent, collimated — a focused beam | Non-coherent — spreads over a broader area |
| Typical use in research | Much of the equine clinical and case-series work (e.g. high-power laser tendon studies) | Fewer equine controlled trials; the notable one (Michanek 2021) was LED and found no benefit |
| Practical strengths | Focused delivery, often higher power, typically vet-administered | Can treat larger and superficial areas; owner-applied; better suited to wearables |
| Shared basis | Both act through the same photochemical mechanism — photon absorption by cytochrome c oxidase | |
Both laser and LED work through the same underlying biology, so this is not a claim that LEDs are ineffective in principle. But it is an honest caution: when a marketing page cites equine laser studies to support an LED consumer product, the mechanism transfers while the specific clinical evidence does not transfer cleanly — and the one prominent equine LED trial was a null result. This is a good example of reading claims carefully rather than accepting "research shows" at face value. For how these findings inform realistic day-to-day use, our comparison with therapeutic ultrasound looks at how PBM's evidence stacks up against another common rehab modality.
How to Read the Claims You Will See Online
Because "red light therapy horse research" is so often used as a marketing hook, it is worth having a short checklist for evaluating any evidence claim you encounter — including on this site.
| Red flags (read sceptically) | Green flags (more trustworthy) |
|---|---|
| "Studies show" with no specific study named | Names the study, year, and journal so you can check it |
| Cites in vitro, rodent, or human studies as proof of equine clinical benefit | Distinguishes cell, animal-model, and equine clinical evidence clearly |
| Presents case series as if they prove cause and effect | Notes when a study lacks a control group and what that limits |
| Ignores dose, penetration, and coat-colour effects | Acknowledges that delivered dose depends on coat, skin, and settings |
| Only cites positive studies; never mentions null results | Engages with null studies (like the 2021 wound RCT) honestly |
| Describes the science as "proven" or "settled" | Describes the evidence as developing, with real limitations |
The Honest Bottom Line: A Reasonable Position
Putting the whole body of research together, here is a position that neither overstates nor dismisses what is known.
- The mechanism is real and well established. Red light therapy is biologically plausible and acts through a defined cellular pathway. This is not fringe science.
- Equine cells respond to light in the laboratory. The in vitro foundation for equine applications is genuinely promising.
- Delivered dose is a real and under-appreciated variable. Coat colour, skin, and settings strongly affect how much light reaches the tissue — a crucial consideration the research makes clear.
- Equine clinical proof is limited and mixed. Some case series are encouraging; the best-designed wound RCT found no benefit; reviews call the results inconsistent and the parameters unstandardised.
- The therapy is generally low-risk. Which is part of why it is reasonable to use as a supportive measure even while the clinical evidence develops — the risk-to-plausibility balance is favourable.
What this means for your horse: red light therapy is a reasonable, low-risk, complementary measure to use with realistic expectations and veterinary input — not a proven cure, and not a substitute for a diagnosis or an established treatment. For a specific condition, the research supports using it as one part of a plan your vet oversees, while remaining sceptical of any claim that the science definitively proves it will resolve that condition. The strongest-supported footing is where mechanism, plausibility, and the balance of evidence align — superficial soft-tissue support and general comfort — while confident claims about deep structures and specific cures run ahead of the equine data.
Conclusion: Strong Foundation, Honest Gaps
The research on red light therapy for horses is a study in layers. At the bottom, the foundation is solid: a well-characterised cellular mechanism, shared across mammals, and equine cells that respond to light in the laboratory. This is why the therapy is biologically plausible and widely used, and why it is not reasonable to dismiss it as having no basis.
But the higher you climb toward the living, clinically treated horse, the thinner the evidence becomes. Penetration studies show that getting an effective dose to the target tissue is a real challenge that depends on coat, skin, and settings. The equine clinical trials are few and mixed — a promising case series here, a well-designed null result there — and systematic reviews conclude that animal results are inconsistent and treatment parameters are not standardised. The best-designed equine wound study found no clinically relevant benefit at all.
The honest conclusion is not "it works" or "it doesn't." It is that red light therapy has a strong mechanistic foundation and a developing, still-limited clinical evidence base, and that delivered dose matters enormously. That makes it a defensible, low-risk, complementary measure to use thoughtfully and with realistic expectations — and it makes any marketing that calls the science "proven" or "settled" something to read with a raised eyebrow.
Use the research the way the research asks to be used: as an honest map of what is known and what is not. Treat red light therapy as a supportive tool with genuine plausibility and real limits, keep your vet involved for anything diagnosed, and judge every "studies show" claim — including ours — by whether it names the study, respects the evidence tiers, and tells you about the null results too.
Frequently Asked Questions
Is there scientific research on red light therapy for horses?
Yes, but it is uneven. The mechanism is well established: photons at red and near-infrared wavelengths are absorbed by cytochrome c oxidase in the mitochondria, a pathway characterised across mammals in a very large body of work. In vitro equine research is promising: studies on equine cells, including bone-marrow-derived mesenchymal stem cells, show that equine cells respond to light in a dose-dependent way. But equine-specific controlled clinical trials — the layer that would actually prove clinical benefit in living horses — are limited, and their results are mixed. A well-designed randomised, blinded, controlled study published in Equine Veterinary Journal in 2021 (Michanek et al.) found no clinically relevant benefit of LED red and near-infrared light on experimental wound healing in horses. So research exists at every level, but its strength decreases sharply as you move from the laboratory toward the living, clinically treated horse.
Does red light therapy actually work on horses according to research?
The research supports a cautious, qualified answer rather than a confident yes or no. The mechanism is real and equine cells respond to light in the laboratory, which is why the therapy is biologically plausible. But whether that translates into measurable clinical benefit in living horses is not yet firmly established for most conditions, because the equine clinical trials are limited and inconsistent — some case series report improvement, while at least one well-designed randomised controlled trial found no benefit for wound healing. There is also an equine-specific complication: penetration studies show how much light reaches deeper tissue depends heavily on coat colour, skin, and dose. The reasonable reading is that red light therapy is a biologically plausible, generally low-risk supportive measure with promising mechanistic and in vitro evidence and a still-developing clinical evidence base — not a proven cure. Use it with realistic expectations and veterinary input.
What does the research say about red light therapy for horse tendon and wound healing?
For tendons, the picture is mechanistically encouraging but clinically unproven. In vitro and animal studies suggest light can stimulate fibroblast activity and collagen synthesis, and a case series of 150 sport horses with tendon and ligament injury treated with high-power laser reported favourable outcomes (Pluim et al., 2018). But a case series has no untreated control group, so it cannot prove the light caused the improvement, and equine penetration studies note that delivering an effective dose to a deep tendon is a real challenge. For wounds, the strongest equine evidence is cautionary: a 2021 randomised, blinded, controlled study in Equine Veterinary Journal (Michanek et al.) found no clinically relevant benefit of LED red and near-infrared light compared with untreated control wounds — in fact, the treated wounds took longer to heal completely. Reviews of animal wound studies conclude that results across species remain inconsistent. So the research does not currently support strong claims of accelerated tendon or wound healing in horses.
Why do some studies show red light therapy doesn't work on horses?
There are several likely reasons, and they do not all mean the therapy is useless. The most important is dose delivery: equine penetration studies show that coat colour, skin thickness, skin preparation, and wavelength dramatically affect how much light reaches the target, with light-coloured hair transmitting far more than dark hair. A study applying a modest surface dose over a coat may deliver only a fraction of that energy to the tissue, potentially falling below the therapeutic window. Photobiomodulation also follows a biphasic dose-response, so too little or too much light both produce weaker effects. In the 2021 Equine Veterinary Journal wound study that found no benefit, the applied irradiance was relatively low. Add small sample sizes, differences in devices and protocols, and the difference between coherent laser and non-coherent LED light, and it becomes clear why equine results are inconsistent. Null studies should be read as evidence the therapy is not guaranteed or well-standardised — not dismissed — and they highlight that dose and delivery matter enormously.
Is red light therapy for horses evidence-based?
It is partially evidence-based, and honesty requires distinguishing which parts. The cellular mechanism is strongly evidence-based, supported by decades of research identifying cytochrome c oxidase as the primary chromophore. The response of equine cells to light in the laboratory is evidence-based. But the clinical claim — that applying red light produces reliable, measurable healing or pain relief in living horses — rests on a limited and mixed body of controlled trials, and for many specific conditions the high-quality equine evidence is not there yet. This differs from a therapy that has been rigorously proven, and also from one with no basis at all. The most defensible position is that red light therapy is a biologically plausible, generally low-risk complementary measure with a strong mechanistic foundation and a developing clinical evidence base. It is reasonable to use as supportive care with realistic expectations and veterinary input, while being sceptical of marketing that presents it as definitively proven for specific equine conditions.
Key References
The studies referenced in this article, for readers who wish to check the primary sources. Findings are summarised in our own words; consult the originals for full detail.
- Michanek, P., Toth, T., Bergström, E., Treffenberg-Pettersson, H. and Bergh, A. (2021). Effect of infrared and red monochromatic light on equine wound healing. Equine Veterinary Journal, 53(1), 143–148. doi:10.1111/evj.13266.
- Pluim, M. et al. (2018). Short- and long-term follow-up of 150 sports horses diagnosed with tendinopathy or desmopathy by ultrasonographic examination and treated with high-power laser therapy. Research in Veterinary Science, 119, 232–238. doi:10.1016/j.rvsc.2018.06.003.
- Haussler, K.K. et al. (2020). Effects of low-level laser therapy and chiropractic care on back pain in Quarter horses. Journal of Equine Veterinary Science, 86, 102891. doi:10.1016/j.jevs.2019.102891.
- Duesterdieck-Zellmer, K.F. et al. (2016). Ex vivo penetration of low-level laser light through equine skin and flexor tendons. American Journal of Veterinary Research, 77(9), 991–999. doi:10.2460/ajvr.77.9.991.
- Ryan, T. and Smith, R. (2007). An investigation into the depth of penetration of low level laser therapy through the equine tendon in vivo. Irish Veterinary Journal, 60(5), 295–299. doi:10.1186/2046-0481-60-5-295.
- Peat, F.J. et al. (2018). In vitro effects of high-intensity laser photobiomodulation on equine bone marrow-derived mesenchymal stem cell viability and cytokine expression. Photomedicine and Laser Surgery, 36(2), 83–91. doi:10.1089/pho.2017.4344.
- Zielinska, P. et al. (2020). Effects of photobiomodulation on equine mesenchymal stem cells. Photobiomodulation, Photomedicine, and Laser Surgery.
- Millis, D.L. and Bergh, A. (2023). A systematic literature review of complementary and alternative veterinary medicine: laser therapy. Animals, 13(4), 667. doi:10.3390/ani13040667.
- Lopez, A. and Brundage, C. (2019). Wound photobiomodulation treatment outcomes in animal models. Journal of Veterinary Medicine, 2019, 6320515. doi:10.1155/2019/6320515.
- Passarella, S. and Karu, T. (2014). Absorption of monochromatic and narrow band radiation in the visible and near-IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation. Journal of Photochemistry and Photobiology B, 140, 344–358.
